Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of levodopa with duodenal infusion and oral COMT inhibitors in advanced Parkinson's disease
2008-003581-26Phase 4Completed
- Sponsor
- Uppsala University
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levodopa, carbidopa, entacapone and tolcapone in Parkinson's disease (PD), sponsored by Uppsala University. Primary endpoint: Coefficient of variation of plasma levodopa concentration. Started May 2008; status: completed.
02
Drugs
levodopacarbidopaentacaponetolcapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-003581-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003581-26.